|
ERCC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.836100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.398870E-03 |
| Normal-vs-Stage2 |
5.384100E-03 |
| Normal-vs-Stage3 |
1.953310E-04 |
| Normal-vs-Stage4 |
4.429600E-02 |
| Stage1-vs-Stage2 |
4.068000E-01 |
| Stage1-vs-Stage3 |
2.002200E-01 |
| Stage1-vs-Stage4 |
7.500000E-01 |
| Stage2-vs-Stage3 |
9.393200E-01 |
| Stage2-vs-Stage4 |
3.947800E-01 |
| Stage3-vs-Stage4 |
2.312200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.594800E-04 |
| Normal-vs-AfricanAmerican |
7.095400E-01 |
| Normal-vs-Asian |
1.074320E-02 |
| Caucasian-vs-AfricanAmerican |
4.183800E-02 |
| Caucasian-vs-Asian |
7.172800E-01 |
| AfricanAmerican-vs-Asian |
1.274820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.991600E-02 |
| Normal-vs-Female |
1.776250E-04 |
| Male-vs-Female |
3.450300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.861500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.039800E-03 |
| Normal-vs-Age(61-80Yrs) |
5.207300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.859840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.996800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.897800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.209350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.294600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.331760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.913800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.738500E-02 |
| Classical-VS-Follicular |
2.048800E-01 |
| Classical-VS-Other |
8.444600E-01 |
| Classical-VS-Normal |
8.195500E-03 |
| Tall-VS-Follicular |
3.528400E-01 |
| Tall-VS-Other |
3.663200E-01 |
| Tall-VS-Normal |
1.817030E-04 |
| Follicular-VS-Other |
7.975000E-01 |
| Follicular-VS-Normal |
3.141400E-03 |
| Other-VS-Normal |
2.138400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.80310000000339E-05 |
| Normal-vs-N1 |
1.295770E-03 |
| N0-vs-N1 |
9.608600E-01 |
|
|
